In regenerative peptide therapy, the concept of stacking — combining multiple peptides that target complementary biological pathways — is one of the most clinically interesting developments of the past decade. The GLOW Stack is a prime example: a combination of GHK-Cu (copper peptide), BPC-157, and TB-500 (Thymosin Beta-4 fragment) that addresses skin regeneration and anti-aging from three distinct but interlocking angles. Understanding how each peptide works — and why their combination is more powerful than any one alone — requires a brief look at the biology of tissue aging.
The Biology of Skin Aging: Why Single-Target Approaches Fall Short
Skin aging is not a single process. It involves the progressive breakdown of the extracellular matrix (the structural scaffold of collagen and elastin that gives skin its firmness and elasticity), declining cellular repair capacity, reduced blood vessel density in the dermis, and a shift toward chronic low-grade inflammation. Effective anti-aging intervention at the tissue level requires addressing all of these processes simultaneously — which is precisely the rationale behind the GLOW Stack's three-peptide design.
GHK-Cu: The Extracellular Matrix Architect
GHK-Cu (glycine-histidine-lysine copper) is a naturally occurring tripeptide found in human plasma, urine, and saliva. Its concentration in plasma is approximately 200 ng/mL at age 20 and declines to roughly 80 ng/mL by age 60 — a drop that correlates closely with the visible signs of skin aging. GHK-Cu's primary role is the remodeling and rebuilding of the extracellular matrix.
A comprehensive 2018 review published in the International Journal of Molecular Sciences by Pickart and Margolina documented GHK-Cu's effects on gene expression relevant to skin biology, finding that it stimulates the synthesis of collagen, elastin, and glycosaminoglycans — the three structural components most responsible for skin firmness, elasticity, and hydration.[1] The same review found that GHK-Cu modulates the expression of over 4,000 human genes, with a strong bias toward genes involved in tissue repair, anti-inflammatory responses, and antioxidant defense. Notably, it both stimulates the production of new collagen and simultaneously activates metalloproteinases that break down damaged, cross-linked collagen — a dual action that results in net matrix renewal rather than mere accumulation.
GHK-Cu also promotes angiogenesis (the formation of new blood vessels) and nerve fiber regeneration, both of which are critical for maintaining the metabolic activity and sensory function of aging skin. A 2017 study in Molecules confirmed that GHK-Cu increases nerve growth factor expression and accelerates nerve fiber regeneration in damaged tissue — an effect with implications beyond skin, extending to wound healing and neuroprotection.[2]
BPC-157: The Cellular Repair Accelerator
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. While it is perhaps best known for its effects on tendon and ligament healing, its mechanisms are broadly applicable to any tissue undergoing repair — including the dermis.
BPC-157's core regenerative action involves the upregulation of vascular endothelial growth factor (VEGF) and the activation of the ERK1/2 signaling pathway — a key regulator of cell growth, migration, and angiogenesis.[3] It also activates the FAK-paxillin pathway, which governs cellular adhesion and migration, ensuring that repair cells are efficiently recruited to sites of injury or degradation. A 2025 systematic review published in HSS Journal analyzed 36 studies on BPC-157 in musculoskeletal medicine and concluded that it promotes healing by boosting growth factors, enhancing angiogenesis, and reducing inflammation across multiple tissue types.[4]
Critically for the GLOW Stack's synergy, BPC-157 has been shown to upregulate growth hormone receptor expression in fibroblasts — the cells responsible for producing collagen and maintaining the extracellular matrix. A 2014 study in the Journal of Applied Physiology demonstrated that BPC-157 dose- and time-dependently increased growth hormone receptor gene and protein expression in tendon fibroblasts, effectively making those cells more responsive to growth hormone signaling.[5] This mechanism creates a direct bridge between BPC-157 and the systemic growth hormone environment — a connection that becomes especially relevant in combination protocols.
TB-500: The Cell Migration and Stem Cell Mobilizer
TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring peptide found in virtually every human cell. Its primary mechanism is the regulation of actin — the structural protein that governs cell shape, motility, and division. By binding to G-actin monomers, TB-500 promotes cell migration, a process that is fundamental to wound healing and tissue remodeling.
Beyond actin regulation, TB-500 mobilizes and differentiates stem and progenitor cells, recruiting them to sites of tissue injury or degradation. A landmark study by Malinda et al. documented that Thymosin Beta-4 accelerates wound healing in animal models, increasing reepithelialization by up to 61% over saline controls at 7 days post-wounding and stimulating keratinocyte migration 2–3-fold at concentrations as low as 10 pg.[6] This stem cell mobilization effect is particularly relevant for skin aging, where the depletion of dermal stem cell populations is a key driver of reduced regenerative capacity over time.
TB-500 also exhibits potent anti-inflammatory properties, inhibiting pro-inflammatory cytokines and upregulating anti-inflammatory gene expression — creating the low-inflammation environment that is necessary for effective tissue regeneration.[7]
The Synergy: Why the Stack Is Greater Than the Sum of Its Parts
The GLOW Stack's power lies in the complementary nature of these three mechanisms. GHK-Cu rebuilds the structural scaffold of the extracellular matrix. BPC-157 accelerates cellular proliferation and enhances the sensitivity of repair cells to growth signals. TB-500 ensures that the right cells — including stem cells — are efficiently mobilized and directed to where they are needed. All three peptides independently promote angiogenesis and reduce inflammation, meaning these critical processes are addressed through multiple redundant pathways rather than a single point of intervention.
The result is a regenerative cascade that addresses tissue aging at the extracellular, cellular, and stem cell levels simultaneously. For skin specifically, this translates to improved collagen density and elasticity (GHK-Cu), accelerated repair of micro-damage and enhanced dermal vascularity (BPC-157), and improved recruitment of regenerative cells to aging or damaged tissue (TB-500).
Timeline of Effects
The GLOW Stack's effects unfold across three time horizons. In the short term (days to weeks), the most immediate effects are typically a reduction in inflammation and early improvements in wound healing or skin recovery from procedures. In the medium term (weeks to 2–3 months), more noticeable changes in skin texture, hydration, and tone become apparent as GHK-Cu's collagen-stimulating effects accumulate. In the long term (3+ months of consistent use), the cumulative effects on extracellular matrix remodeling, vascular density, and stem cell activity produce the most significant anti-aging outcomes.
At Nectar Wellness
The GLOW Stack is available at Nectar Wellness as part of our peptide therapy program, prescribed following a comprehensive clinical consultation and baseline assessment. GHK-Cu, BPC-157, and TB-500 come pre-mixed in a single vial and are self-administered at home as one quick subcutaneous injection. Your nurse will provide a thorough training session so you are confident with the technique before beginning your home program. Our clinical team conducts regular check-ins to assess your response and adjust the program as needed.
"GHK-Cu stimulates collagen, elastin, and glycosaminoglycan synthesis while simultaneously activating the metalloproteinases that break down damaged matrix — a dual action that results in net tissue renewal rather than mere accumulation." — Pickart & Margolina, International Journal of Molecular Sciences, 2018

